NCT02772991

Brief Summary

In recent years, a large number of studies have been conducted on how to improve the treatment of patients in the Emergency Room (ER) complaining of chest pains. Great advances have been achieved recently regarding diagnostic methods aided by coronary CT angiopraphy (CCTA) and sensitive troponins. However, various questions about these methods still remain obscure and there is no effective comparison between them in patients with intermediate risk. The aim of the study is to evaluate the sensitivity and specificity of sensitivity troponins in the detection of coronary artery disease in patients with chest pain and the intermediate probability of ACS compared with CCTA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 16, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

February 5, 2018

Status Verified

January 1, 2017

Enrollment Period

1.8 years

First QC Date

April 26, 2016

Last Update Submit

February 2, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants with adverse events according to phone contact after 30 days

    Patients whose CCTAs show lesions with stenosis of less than 50%, compare combined outcomes (death, AMI, rehospitalization, and stroke)with the increase/decrease of troponin in the second measurement in 30 days according to phone contact.

    30 days

  • Compare the sensitivity, specificity, and negative and positive predictive values between the high sensitivity troponin and the CCTA in the detection of an ACS.

    ROC curve / ANOVA

    30 days

Secondary Outcomes (1)

  • Stablish the cut off for troponin levels

    3 hours

Study Arms (1)

Cases

EXPERIMENTAL

All patients will be submmited to troponin measurements and CCTA. If CCTA shows coronary stenosis ≥ 50%, patient will initiate the ACS treatment and be hospitalized to have coronary cineangiography. If CCTA shows lesions \< 50%, the patient will be discharged and monitored for 30 days. A second sampling of the troponin will be obtained from all patients three hours after the first collection in order to evaluate for an increase/decrease of troponin.

Other: troponin measurement

Interventions

Cardiac catheterization (for patients with \>50% lesions) or discharge or in patients with intermediate risk.

Also known as: coronary CT angiopraphy
Cases

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chest pain for at least two hours before arriving at the emergency unit
  • non-diagnostic electrocardiogram (absence of new or probable deviation of ST of at least 0.5 mV and/or T wave inversion of at least 0.2 mV)
  • TIMI risk of 3 or 4
  • first measurement of troponin I less than or equal to ≤ 0.03 ng/ml
  • informed consent form signed.

You may not qualify if:

  • pregnancy
  • hemodynamic instability (pulmonary congestion / systolic arterial pressure lower than 90 mmHg)
  • serum creatinine higher than 1.5 mg/dL
  • intolerance to ß-blockers
  • allergy to iodinated contrast
  • asthma
  • thoracic trauma within the last 30 days
  • body mass index greater than 40 kg/ m2
  • previous surgical myocardial revascularization
  • other identified causes of troponin increase

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto do Coração - HMFMUSP

São Paulo, 05403000, Brazil

Location

MeSH Terms

Conditions

Chest PainAcute Coronary Syndrome

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2016

First Posted

May 16, 2016

Study Start

March 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2018

Last Updated

February 5, 2018

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations